Recently, the Delaware Chancery Court and the Third Circuit issued three significant decisions on key issues affecting licensing and M&A transactions in the life sciences industry....more
9/16/2024
/ Acquisitions ,
Breach of Contract ,
Commercially Reasonable Efforts ,
Due Diligence ,
Earn-Outs ,
IP License ,
Johnson & Johnson ,
Life Sciences ,
Medical Devices ,
Mergers ,
Patents ,
Pharmaceutical Industry ,
Royalties ,
Shareholders
Intellectual property protection is more important than ever in the beauty industry as the market for cosmetics becomes more crowded and competitive.
Some cosmetic companies have used patents as a key tool to...more
In 2021, the FDA’s Purple Book went live, providing a searchable database of licensed biological products, including the patent information provided to biosimilar applicants during the patent dance. Pursuant to a law enacted...more